From launch to leadership: the Devilam brand turns two

The Devilam brand (colecalciferol, vitamin D3) is celebrating its second anniversary. During this time, the prescription vitamin D drug has successfully gained a foothold in the Russian market, become one of the leaders in its category, and gained recognition from doctors and patients.

The high standing of the Devilam drug on the pharmaceutical market is confirmed by authoritative industry ratings and competitions:

• 2nd place in the launch rating by the number of healthcare professional engagements, according to the monitoring results of «Ipsos Comcon»;

• 2nd place among high-dose (>4,000 IU) vitamin D medications, 3rd place in the Rx segment for vitamin D drugs, and 6th place overall among vitamin D medications, according to DSM Group;

• 3rd place in the subcategory «Launch of the Year. Retail Segment» of the All-Russian Open Competition for Pharmaceutical Industry Professionals «Platinum Ounce»;

• 5th place in the top-10 launch brands by doctor prescriptions, according to the «Prindex» rating;

• 6th place in the top-10 of the «AlphaRM» rating for pharmacy sales of vitamin D.

«Two years ago, we introduced the Russian market to not just another colecalciferol, but a drug focused on the real needs of doctors and patients. Its recognition by the professional community and high positions in ratings have proven that we chose the right strategy. The company intends to continue strengthening trust in the Devilam brand by investing in its promotion for the benefit of people's health», said Ivan Khalepo, General Director of JSC Avexima.